Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...

Innovative organ-on-chip specialist Dynamic42 and ESQlabs, experts in digital life sciences solutions, have successfully ...

Tracking targeted drug delivery is often a challenge due to limitations in the current imaging techniques. A recent study reports a breakthrough imaging technique that allows direct and highly ...

Tracking targeted drug delivery is often a challenge due to limitations in current imaging techniques. A recent study by ...

A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have ...

Drug More Than Doubles Survival Time for Glioblastoma Patients Mar. 7, 2025 — Researchers have developed a drug shown to significantly extend survival time for patients with glioblastoma ...

Noncompartmental methods were used to determine pharmacokinetic parameters ... route potentially improves systemic bioavailability of drugs since it bypasses gastrointestinal degradation and ...

Phase I trial results show the potential of once-yearly lenacapavir as a long-acting PrEP option for HIV, supporting further ...

Students will explore the effects of venoms, poisons, drugs and everyday chemicals on the human body, receiving expert-level instruction and hands-on training at the college’s Arizona Poison and Drug ...

The first patient with small cell lung cancer has been dosed in a trial of peluntamig (PT217) combined with chemotherapy.

Ascletis Pharma Inc. (ASCLF.PK) announced promising pharmacokinetic and weight loss data from its ASC47 Phase Ib single subcutaneous injection studies conducted in Australia.

MIRA Pharmaceuticals gains approval for a Phase 1 trial of Ketamir-2 in Israel, aiming to complete by Q4 2025 before moving ...